McKesson Corporation NYSE:MCK

McKesson stock price today

$676.6
+99.96
+17.33%
Financial Health
0
1
2
3
4
5
6
7
8
9

McKesson stock price monthly change

-0.00%
month

McKesson stock price quarterly change

-0.00%
quarter

McKesson stock price yearly change

+26.04%
year

McKesson key metrics

Market Cap
72.45B
Enterprise value
77.90B
P/E
29.26
EV/Sales
0.23
EV/EBITDA
16.15
Price/Sales
0.22
Price/Book
-24.59
PEG ratio
3.67
EPS
14.25
Revenue
279.98B
EBITDA
4.36B
Income
1.93B
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0.77%
Oper. margin
1.11%
Gross margin
3.88%
EBIT margin
1.11%
EBITDA margin
1.56%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

McKesson stock price history

McKesson stock forecast

McKesson financial statements

Average Price Target
Last Year

$614.75

Potential downside: -9.14%

Based on estimate of 7 analysts
  • Analysts Price target

  • Financials & Ratios estimates

McKesson Corporation (NYSE:MCK): Profit margin
Dec 2021 68.61B -7M -0.01%
Mar 2022 66.10B 368M 0.56%
Mar 2023 68.91B 787M 1.14%
Mar 2024 76.35B 791M 1.04%
0.46%
Yield TTM
McKesson Corporation (NYSE:MCK): Payout ratio
Payout ratio 12.89%
McKesson Corporation (NYSE:MCK): Dividend Yield
2020 1.2%
2021 0.88%
2022 0.59%
2023 0.58%
2024 0.44%
McKesson Corporation (NYSE:MCK): Debt to assets
Sep 2022 63081000000 64.33B 101.98%
Dec 2022 62690000000 64.77B 103.33%
Mar 2023 62320000000 63.81B 102.39%
Mar 2024 67443000000 69.04B 102.37%
McKesson Corporation (NYSE:MCK): Cash Flow
Dec 2021 1.37B -115M -438M
Mar 2022 2.88B 183M -1.98B
Mar 2023 3.32B -244M -1.19B
Mar 2024 4.14B -577M -968M

McKesson alternative data

McKesson Corporation (NYSE:MCK): Employee count
Aug 2023 45,000
Sep 2023 45,000
Oct 2023 45,000
Nov 2023 45,000
Dec 2023 45,000
Jan 2024 45,000
Feb 2024 45,000
Mar 2024 45,000
Apr 2024 45,000
May 2024 45,000
Jun 2024 45,000
Jul 2024 45,000

McKesson other data

83.97% +1.81%
of MCK is owned by hedge funds
127.29M -703.53K
shares is hold by hedge funds

McKesson Corporation (NYSE:MCK): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 3908
Feb 2024 0 186
Mar 2024 0 3663
May 2024 0 23949
Jun 2024 0 4836
Jul 2024 0 3753
Aug 2024 0 3753
Sep 2024 0 3753
Dec 2024 0 579
Transaction Date Insider Security Shares Price per share Total value Source
Sale
SMITH LEANN B officer: EVP & Chief HR Officer
Common Stock 579 $602.81 $349,027
Sale
TYLER BRIAN S. director, officer: Chief Execut..
Common Stock 3,753 $561.1 $2,105,808
Sale
TYLER BRIAN S. director, officer: Chief Execut..
Common Stock 3,753 $626.03 $2,349,491
Sale
TYLER BRIAN S. director, officer: Chief Execut..
Common Stock 3,753 $580.92 $2,180,193
Sale
SMITH LEANN B officer: EVP & Chief HR Officer
Common Stock 600 $585.53 $351,318
Sale
MARTINEZ MARIA director Common Stock 483 $585.88 $282,979
Sale
TYLER BRIAN S. director, officer: Chief Execut..
Common Stock 3,753 $574.41 $2,155,761
Sale
RODGERS THOMAS L officer: EVP, Chief Strategy & ..
Common Stock 5,232 $560.99 $2,935,100
Sale
VITALONE BRITT J. officer: EVP & CFO Common Stock 2,427 $550 $1,334,850
Sale
VITALONE BRITT J. officer: EVP & CFO Common Stock 2,427 $550 $1,334,850
Patent
Grant
Filling date: 31 Mar 2016 Issue date: 13 Sep 2022
Grant
Filling date: 31 Mar 2020 Issue date: 30 Aug 2022
Grant
Filling date: 9 Nov 2020 Issue date: 16 Aug 2022
Grant
Filling date: 31 Mar 2021 Issue date: 26 Jul 2022
Grant
Filling date: 27 Aug 2019 Issue date: 19 Jul 2022
Grant
Filling date: 31 Mar 2017 Issue date: 12 Jul 2022
Grant
Filling date: 29 Mar 2019 Issue date: 31 May 2022
Grant
Filling date: 5 Mar 2021 Issue date: 3 May 2022
Grant
Filling date: 23 Mar 2020 Issue date: 15 Feb 2022
Grant
Filling date: 31 Mar 2020 Issue date: 30 Nov 2021
Insider Compensation
Mr. Brian S. Tyler Ph.D. (1967) Chief Executive Officer & Director
$3,340,000
Ms. Lori A. Schechter J.D. (1962) Executive Vice President, Chief Legal Officer & Gen. Counsel $2,300,000
Mr. Britt J. Vitalone (1969) Executive Vice President & Chief Financial Officer $2,290,000
Mr. Thomas Rodgers M.B.A., MBA (1971) Executive Vice President and Chief Strategy & Bus. Devel. Officer
$2,230,000
Ms. Tracy L. Faber (1970) Executive Vice President & Chief HR Officer $1,350,000
Wednesday, 25 December 2024
zacks.com
Monday, 23 December 2024
zacks.com
Friday, 20 December 2024
zacks.com
zacks.com
zacks.com
Thursday, 19 December 2024
zacks.com
zacks.com
Wednesday, 18 December 2024
zacks.com
zacks.com
zacks.com
Monday, 16 December 2024
zacks.com
zacks.com
zacks.com
Friday, 13 December 2024
zacks.com
Thursday, 12 December 2024
zacks.com
zacks.com
Wednesday, 11 December 2024
zacks.com
Saturday, 7 December 2024
seekingalpha.com
Friday, 6 December 2024
247wallst.com
Wednesday, 4 December 2024
seekingalpha.com
Wednesday, 27 November 2024
zacks.com
Tuesday, 26 November 2024
zacks.com
Thursday, 21 November 2024
zacks.com
zacks.com
Wednesday, 13 November 2024
zacks.com
zacks.com
zacks.com
Monday, 11 November 2024
zacks.com
zacks.com
zacks.com
  • What's the price of McKesson stock today?

    One share of McKesson stock can currently be purchased for approximately $676.6.

  • When is McKesson's next earnings date?

    Unfortunately, McKesson's (MCK) next earnings date is currently unknown.

  • Does McKesson pay dividends?

    Yes, McKesson pays dividends and its trailing 12-month yield is 0.46% with 13% payout ratio. The last McKesson stock dividend of $0.47 was paid on 3 Jan 2022.

  • How much money does McKesson make?

    McKesson has a market capitalization of 72.45B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 11.65% to 308.95B US dollars.

  • What is McKesson's stock symbol?

    McKesson Corporation is traded on the NYSE under the ticker symbol "MCK".

  • What is McKesson's primary industry?

    Company operates in the Healthcare sector and Medical - Distribution industry.

  • How do i buy shares of McKesson?

    Shares of McKesson can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are McKesson's key executives?

    McKesson's management team includes the following people:

    • Mr. Brian S. Tyler Ph.D. Chief Executive Officer & Director(age: 58, pay: $3,340,000)
    • Ms. Lori A. Schechter J.D. Executive Vice President, Chief Legal Officer & Gen. Counsel(age: 63, pay: $2,300,000)
    • Mr. Britt J. Vitalone Executive Vice President & Chief Financial Officer(age: 56, pay: $2,290,000)
    • Mr. Thomas Rodgers M.B.A., MBA Executive Vice President and Chief Strategy & Bus. Devel. Officer(age: 54, pay: $2,230,000)
    • Ms. Tracy L. Faber Executive Vice President & Chief HR Officer(age: 55, pay: $1,350,000)
  • How many employees does McKesson have?

    As Jul 2024, McKesson employs 45,000 workers.

  • When McKesson went public?

    McKesson Corporation is publicly traded company for more then 30 years since IPO on 10 Nov 1994.

  • What is McKesson's official website?

    The official website for McKesson is mckesson.com.

  • Where are McKesson's headquarters?

    McKesson is headquartered at 6555 State Highway 161, Irving, TX.

  • How can i contact McKesson?

    McKesson's mailing address is 6555 State Highway 161, Irving, TX and company can be reached via phone at +972 4464800.

  • What is McKesson stock forecast & price target?

    Based on 7 Wall Street analysts` predicted price targets for McKesson in the last 12 months, the avarage price target is $614.75. The average price target represents a -9.14% change from the last price of $676.6.

McKesson company profile:

McKesson Corporation

mckesson.com
Exchange:

NYSE

Full time employees:

45,000

Industry:

Medical - Distribution

Sector:

Healthcare

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

6555 State Highway 161
Irving, TX 75039

CIK: 0000927653
ISIN: US58155Q1031
CUSIP: 58155Q103